164 related articles for article (PubMed ID: 22342302)
1. Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.
Tucker SL; Dong L; Michalski JM; Bosch WR; Winter K; Cox JD; Purdy JA; Mohan R
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):390-5. PubMed ID: 22342302
[TBL] [Abstract][Full Text] [Related]
2. Estimation of α/β for late rectal toxicity based on RTOG 94-06.
Tucker SL; Thames HD; Michalski JM; Bosch WR; Mohan R; Winter K; Cox JD; Purdy JA; Dong L
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):600-5. PubMed ID: 21377288
[TBL] [Abstract][Full Text] [Related]
3. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
4. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.
Hamstra DA; Stenmark MH; Ritter T; Litzenberg D; Jackson W; Johnson S; Albrecht-Unger L; Donaghy A; Phelps L; Blas K; Halverson S; Marsh R; Olson K; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1246-53. PubMed ID: 23265567
[TBL] [Abstract][Full Text] [Related]
5. Random forests to predict rectal toxicity following prostate cancer radiation therapy.
Ospina JD; Zhu J; Chira C; Bossi A; Delobel JB; Beckendorf V; Dubray B; Lagrange JL; Correa JC; Simon A; Acosta O; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1024-1031. PubMed ID: 25035205
[TBL] [Abstract][Full Text] [Related]
6. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
Strigari L; Arcangeli G; Arcangeli S; Benassi M
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
[TBL] [Abstract][Full Text] [Related]
7. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
Cheung R; Tucker SL; Ye JS; Dong L; Liu H; Huang E; Mohan R; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1513-9. PubMed ID: 15050331
[TBL] [Abstract][Full Text] [Related]
8. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
Moore KL; Schmidt R; Moiseenko V; Olsen LA; Tan J; Xiao Y; Galvin J; Pugh S; Seider MJ; Dicker AP; Bosch W; Michalski J; Mutic S
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):228-35. PubMed ID: 25847605
[TBL] [Abstract][Full Text] [Related]
9. Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
Tucker SL; Dong L; Bosch WR; Michalski J; Winter K; Mohan R; Purdy JA; Kuban D; Lee AK; Cheung MR; Thames HD; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1253-60. PubMed ID: 20598811
[TBL] [Abstract][Full Text] [Related]
10. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
[TBL] [Abstract][Full Text] [Related]
11. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
[TBL] [Abstract][Full Text] [Related]
12. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
14. Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.
Gulliford SL; Partridge M; Sydes MR; Webb S; Evans PM; Dearnaley DP
Radiother Oncol; 2012 Mar; 102(3):347-51. PubMed ID: 22119373
[TBL] [Abstract][Full Text] [Related]
15. Influence of image slice thickness on rectal dose-response relationships following radiotherapy of prostate cancer.
Olsson C; Thor M; Liu M; Moissenko V; Petersen SE; Høyer M; Apte A; Deasy JO
Phys Med Biol; 2014 Jul; 59(14):3749-59. PubMed ID: 24936956
[TBL] [Abstract][Full Text] [Related]
16. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.
Benadjaoud MA; Blanchard P; Schwartz B; Champoudry J; Bouaita R; Lefkopoulos D; Deutsch E; Diallo I; Cardot H; de Vathaire F
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):654-63. PubMed ID: 25304951
[TBL] [Abstract][Full Text] [Related]
17. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy.
Dale E; Olsen DR; Fosså SD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):385-91. PubMed ID: 10030266
[TBL] [Abstract][Full Text] [Related]
18. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
19. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
[TBL] [Abstract][Full Text] [Related]
20. Rectal complication probability from composite volumes derived from daily cone beam computed tomography in prostate cancer radiotherapy.
Prabhakar R; Oates R; Daryl J; Chang J; Geso M; Cramb J
J Cancer Res Ther; 2016; 12(1):374-8. PubMed ID: 27072266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
